Alto Neuroscience, Inc. (ANRO) Misses Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts ANRO Hot Sheet
Join SI Premium – FREE
Alto Neuroscience, Inc. (NYSE: ANRO) reported Q2 EPS of ($0.65), $0.05 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Morgan Stanley Starts OGE Energy (OGE) at Equalweight
- BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
